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Abstract
Background: Amyloid beta (Ab) accumulates in the ageing central nervous system and is associated with a number of age-
related diseases, including age-related macular degeneration (AMD) in the eye. AMD is characterised by accumulation of
extracellular deposits called drusen in which Ab is a key constituent. Ab activates the complement cascade and its
deposition is associated with activated macrophages. So far, little is known about the quantitative measurements of Ab
accumulation and definitions of its relative sites of ocular deposition in the normal ageing mouse.
Methodology/Principal Findings: We have traced Ab accumulation quantitatively in the ageing mouse retina using
immunohistochemistry and Western blot analysis. We reveal that it is not only deposited at Bruch’s membrane and along
blood vessels, but unexpectedly, it also coats photoreceptor outer segments. While Ab is present at all sites of deposition
from 3 months of age, it increases markedly from 6 months onward. Progressive accumulation of deposits on outer
segments was confirmed with scanning electron microscopy, revealing age-related changes in their morphology. Such
progress of accumulation of Ab on photoreceptor outer segments with age was also confirmed in human retinae using
immunohistochemistry. We also chart the macrophage response to increases in Ab showing up-regulation in their numbers
using both confocal laser imaging of the eye in vivo followed by in vitro immunostaining. With age macrophages become
bloated with cellular debris including Ab, however, their increasing numbers fail to stop Ab accumulation.
Conclusions: Increasing Ab deposition in blood vessels and Bruch’s membrane will impact upon retinal perfusion and
clearance of cellular waste products from the outer retina, a region of very high metabolic activity. This accumulation of Ab
may contribute to the 30% reduction of photoreceptors found throughout life and the shortening of those that remain. The
coating of Ab on outer segments may also have an impact upon visual function with age.
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Introduction
Age-related macular degeneration (AMD) is the leading cause of
blindness in those over 50 years in the Western industrialized
world [1–3] and is characterized by the formation of drusen,
which are extracellular deposits between the retinal pigment
epithelium (RPE) and Bruch’s membrane [4–6]. These deposits
result in disturbance in the transepithelial barrier, RPE atrophy,
and subsequent degeneration of the neural retina [7]. One of the
key constituents of drusen is amyloid beta (Ab), a protein also
present in the brain of Alzheimer’s disease (AD) patients [8–11].
Ab causes RPE alterations and dysfunctions leading to retinal
degeneration [12]. It is also an activator of the complement
cascade and associated with microglia, astrocytes and dendritic cell
activation [13–16]. The presence of these cells may be indicative
of an attempt to clear Ab [17–20], but it has also been suggested
that they may play a role in disease development [21–23].
Much has been undertaken to study Ab depositions in the brain
of mice models of AD, [24–28], however, the retina have received
less attention. Three recent studies investigated retinal changes in
transgenic AD mouse models. Ning et al. have shown age-
dependent Ab accumulation in the retina, especially in the nerve
fibre layer and choriocapillaris, possibly resulting in neurodegen-
eration [29]. Furthermore, Perez et al. revealed that in the AD
mouse retina, there are an age-dependent formation of Ab
plaques, microglial activation, and a functional deficit [30].
Neither observed these changes in age-matched wild-type animals.
Dutescu et al., on the other hand, have quantified the amount of
amyloid precursor protein (APP) proteolytic products in the retina
of transgenic mice models of AD and in normal C57Bl/6/SJL
using ELISA and Western blot [31]. In the retina, they have found
only trace amounts of Ab even in transgenic AD mice, indicating
minor importance of Ab in retinal toxicity than suggested by other
immunochemical studies.
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13127To date accumulation of the Ab in the retina has mostly been
studied in the transgenic AD murine models to investigate
whether toxic Ab in the retina may cause visual disturbances in
patients with AD. However, to our knowledge there is no data on
Ab accumulation in the mouse retina as a part of a normal
ageing process. Therefore, our aim was to quantitate the
progressive accumulation of Ab in normal murine ageing
retinae using three independent methods to reveal diverse
deposition sites and to investigate the relationship between the
macrophages and Ab.W er e v e a lt h a tak e ys i t ef o rA b
accumulation is on the membrane of the photoreceptor outer
segments as well as on blood vessels and Bruch’s membrane. We
also relate these data with quantitative assessment of macro-
phage recruitment using both in vivo retinal imaging and
immunohistochemistry.
Results
Imaging and age-dependent accumulation of subretinal
macrophages
Fundus autofluorescence images taken using the confocal
scanning laser ophthalmoscope (cSLO) at 3, 6, 12 and 24 months
revealed an age-dependent increase in the number of hyperauto-
fluorescence spots in sub-retinal regions (Figure 1A). These spots
were variable in number but appeared to increase markedly in
animals over 6 months of age. When the imaged eyes were
subsequently processed histologically for the macrophage marker
Iba-1, there was a tight correlation between the hyperautofluor-
escence sources in vivo and the Iba-1 positive cells when the images
were overlaid (Figure 1B), hence they are macrophage/microglia
cells, a point also noted by Xu, et al. [32]. More that 95% of the
Figure 1. Retinal imaging and macrophage histology. A. Scanning laser ophthalmoscope images of the retinae of mice taken at 3, 6, 12 and 24
months of age. With time there is an accumulation of fluorescent point sources. B. The images are overlaid with the eyecups of a 12 months old
mouse once they have been stained for Iba-1 to reveal macrophages and Ab. This shows that many of the point sources are macrophages containing
Ab (indicated with arrows). These are arranged in a grid like pattern. C. A higher power image of Ab containing macrophages of a 12 months old
mouse. D. The number of macrophages present in the whole mounts at progressive ages. There are significant increases at 12 and 24 months (see
text for statistics).
doi:10.1371/journal.pone.0013127.g001
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amount of Ab in these cells appeared to increase with age. As with
the hyperautofluorescence point sources, the number of microglia
increased significantly with age (Figure 1D; ANOVA P,0.05).
Changes were, however, less marked between 3 and 6 months, but
they were significant between these early stages and 12 and 24
months (P,0.05 in both cases). They were also significant between
12 and 24 months (P,0.05). The Iba-1 positive cells were
morphologically ramified dendriform and regularly distributed in
the sub-retinal space in a mosaic like pattern. The distance
between these cells when they were clustered did not change over
time but their dentritic processes shortened (P,0.05), perhaps
suggesting that they are less efficient in the removal of cellular
debris as they cover less surface area (Figure 2A and B). When the
Iba-1 positive cells were on their own and not in cluster, the length
of the dendritic processes did not change over time (Figure 2C).
Age-dependent accumulation of Ab in mouse and
human eyes
Immunostaining of sections containing the retina and RPE
revealed that Ab expression was primarily present at the level of
the photoreceptor outer segment and the Bruch’s membrane/RPE
interface, along with retinal and choroidal blood vessels. Within
these regions Ab was present even at 3 months of age, and from
this point there was a clear age-related accumulation of this
material at these sites (Figure 3A). The accumulation of Ab is
presented quantitatively for integrated density at the Bruch’s
membrane/RPE interface and for the photoreceptor outer
segments in immunohistochemical preparations (Figure 3B and
3C) and using Western blot analysis (Figure 3D and 3E). No
attempt was made to examine Iba-1 positive cells in section, as
only their processes could be commonly identified in such
preparations, therefore, reliable counts were not possible.
Ab deposition on Bruch’s membrane/RPE interface increased
in stages from 3–6 months and from 6–12 months in immuno-
stained tissue. The difference over the 3 time periods shown in
Figure 3B was significant (ANOVA P,0.001). Post-hoc testing
revealed that differences between 3 and 12 months and 6 and 12
months were significant (P,0.001; P,0.005, respectively). Similar
patterns were found with Ab deposition over time around
photoreceptor outer segments (Figure 3C). Differences in age
groups were significant (ANOVA P,0.0001). Post-hoc testing
revealed that significant differences were between 3 and 12 months
and 6 and 12 months (P,0.0001; P,0.0001 respectively), but not
between intermediate stages.
Ab staining of whole mounted retinae also revealed the age-
dependent accumulation of Ab in retinal blood vessels. When the
tissue was sectioned to examine the accumulation of Ab in other
retinal regions it was clear that it also accumulated in the choroidal
blood supply. Here specific vessels became heavily labelled while
others appeared to be devoid of Ab (Figure 4). To confirm the
presence of Ab in the choroidal vasculature, another method of
immunohistochemistry was performed using a colorimetric
staining to rule out all background staining that might result in
false positive staining.
Western blot analysis was also undertaken to quantify age-
related changes in Ab deposition in the mouse RPE/Bruch’s
membrane interface and in the retina. This showed a significant
increase in Ab with age (Figure 3F and 3G; ANOVA P,0.05).
The two most distinct oligomers of Ab present in the retina and
RPE were the hexamers (22–36 kDa) and docecamers (50–
64 kDa). In the mouse RPE/Bruch’s membrane interface, post-
hoc testing demonstrated significant differences between 3 and 6
months and 3 and 12 months (P,0.05; P,0.05 respectively;
Figure 3D and 3F). Differences between 6 and 12 months were not
significant. In the retina a similar pattern was found (Figure 3E
and 3G). Post-hoc testing showed that differences were significant
Figure 2. Graphs showing the distance between macrophages
and measurement of the dendritic processes. A. Graph showing
the distance between macrophages in a cluster of seven cells for the 12
months and six cells for the 24 months old mouse. B. Graph showing the
length of the dendritic processes of these seven cells of the 12 months
and six cells of the 24 months old mouse (P,0.01). C. Graph showing the
length of the dendritic processes of eight individual macrophage cells for
the 12 months and four individual cells for the 24 months old mouse.
doi:10.1371/journal.pone.0013127.g002
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PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13127Figure 3. Ab is deposited at the Bruch’s membrane (BM)/RPE interface and among photoreceptor outer segments. A. The
accumulation of amyloid beta in sections showing BM/RPE interface and the regions of the outer segments (OS) in mice of 3, 6 and 12 months age.
Here Ab label is red and the outer nuclear layer (ONL) is blue. This progressive accumulation was quantified with two independent methods at the
two sites. First, the integrated density of label from immunostained sections was measured. The results of this are shown graphically in B and C. There
are significant increases at both sites, particularly at 12 months (see text for levels of significance). Second, Western blots were run for Ab at each site
shown in D and E. F and G show the measurements at the same three time points as in B and C. The amount of Ab increases significantly over time
(see text for levels of significance). Differences between B and C and F and G are probably due to the different amounts of tissue sampled as F and G
will also include measures derived from inner and outer retinal blood vessels.
doi:10.1371/journal.pone.0013127.g003
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respectively). These results are largely consistent with that found
using immunohistochemistry. The differences at the 6 month
stages could be due to the differences in the volumes of the tissue
sampled and their origins, as the Western blots included choroidal
and retinal blood vessels. If rates of Ab accumulation in these
differed from those in the outer retina and at the Bruch’s
membrane/RPE interface some variation between immunohisto-
chemical and Western blot analysis might be expected.
To determine whether similar patterns of Ab accumulation
were present in photoreceptor outer segments in human tissue,
four human retinae spanning 31–90 years were immunostained.
We observed an increase of Ab deposition with age (Figure 5).
Although only one retina at each time point was examined with
only one method, the results are very similar to that found in mice,
with a marked accumulation of Ab over time. The drop observed
in the accumulation of Ab in the 90 year old retina may be due to
age-related loss and shortening of photoreceptors [33].
Scanning Electron Microscopy imaging of photoreceptor
outer segments
The results presented above reveal quantitative increases in Ab
deposition with age in mouse using immunohistochemistry and
Western blots. Although these results combine two quantitative
methods for measuring Ab accumulation, the presence of this
material was unexpected on photoreceptor outer segments.
Consequently, a third method, scanning electron microscopy
(EM), was adopted to investigate this deposition in tissue taken at
3, 6, 12 and 24 months (Figure 6). This analysis reveals an
increasing accumulation of highly fragmented material on the
outer segments with age. This stops at the inner–outer segment
junction of the photoreceptor, which reflects the patterns seen
using immunohistochemistry.
Deposition can be identified at 3 months and it is more
prominent along outer regions of the outer segment at this stage.
The amount of material found here increases between 3–6 months
(Figure 6). Consistent with the immunostaining (Figure 3C), there
was a marked increase in this material at 12 months. At this stage
the outer segments appear almost completely wrapped in the
material. At 24 months the outer segments appeared qualitatively
different as many had enlarged tips (Figure 6). This may be
indicative of less efficient patterns of phagocytosis by RPE cells,
which remove the end of the photoreceptors daily to compensate
for the addition of new photoreceptor disks at the outer segments
base [34,35]. For such reasons, it was not possible to determine
whether more debris accumulated on them than at earlier times.
At all stages, there is no direct proof that the debris that
accumulates on outer segments is Ab but the close association
between immunostaining patterns and the scanning EM images
would argue that Ab was at least an element of such deposits.
Figure 4. Retinal blood vessels stained for Ab. A. Inner retinal vessels stained for Ab (red), Iba-1 (green) and neuronal cell bodies (blue) at 24
months. The amyloid deposits can be seen to be at focal points along the vessel rather than being continuous. B. Choroidal vessels also accumulated
Ab, however, the accumulation of this material appeared to be specific to a sub-group of vessels with other showing no sign of Ab accumulation. This
is taken from a 12 months old animal. C. Immunostaining of retinal section of a 12 months old animal using the colorimetric method (3,3-
diaminobenzidine) to confirm the presence of Ab in the outer segment of the photoreceptor and in the blood vessels. D. Negative control of the
colorimetric staining showing the absence of staining.
doi:10.1371/journal.pone.0013127.g004
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outersegments,butalsoa markedchangeinitsappearancebetween
that found at 3–6 months and that present at 12 months. At the
earlier stages, the deposits tend to be spherical or to have rounded
edges. At 12 months and after, spherical bodies could also be
identified. The majority of the deposits, however, now appeared to
havea fragmented wire likeappearance.In many cases, the deposits
adopted a morphology similar to ruptured spheres, leaving angular
edges on the side of a distorted hemisphere (Figure 7).
Discussion
Ab is a known constituent of drusen [7,8,36], which are age-
related deposits found on Bruch’s membrane in the human and
key risk factors for developing AMD [37–39]. In this study, we
demonstrate site specific age-related accumulation of Ab in the
normal mouse retina. This occurs primarily among photoreceptor
outer segments and on the RPE/Bruch’s membrane interface.
Two of the independent methods employed are quantitative and
Figure 5. Ab staining in human outer retina from individuals aged 31, 47, 80 and 90 years. This was undertaken on retinae separated from
the RPE. Ab is red and the outer nuclear layer (ONL) is blue. The outer segments (OS) are positive for Ab but the intensity of the staining increases
with age. In spite of this, the overall progression of Ab accumulation here mirrors that found in mice.
doi:10.1371/journal.pone.0013127.g005
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PLoS ONE | www.plosone.org 6 October 2010 | Volume 5 | Issue 10 | e13127Figure 6. Scanning electron micrographs of photoreceptor outer segments taken from animals at 3, 6, 12 and 24 months of age. In
each case the right hand panel is a higher magnification of that on the left and the orientation is such that the RPE would be to the top and the outer
nuclear layer to the bottom. Even at 3 months of age deposits can be found on outer segments, however they are more common towards the tip of
the outer segment than the base. They are largely spherical in morphology or have rounded edges. By 6 months, their coating has increased and the
deposits are present along the length of the outer segment. At 12 months the deposits have thickened, but also appear to have changed
qualitatively (See Figure 7). At 24 months while thick deposits remain the tips of many outer segments have enlarged and those that remain are
shorter making direct comparison with earlier stages difficult.
doi:10.1371/journal.pone.0013127.g006
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scanning EM, provides structural images for the potential Ab
containing elements deposited on outer segments. We also show in
vitro and in vivo that there is an age-related accumulation of
macrophages that internalise Ab and appear to establish individual
exclusion territories. As such, this is the first comprehensive
quantitative analysis of age-related Ab accumulation in the normal
murine retina. Further, we extend these studies by examining Ab
deposition on outer segments in the human retinae using
immunostaining, showing that as in mice, this material accumu-
lates with age.
Although previous studies have investigated the presence and
accumulation of Ab in the retina, their work was different from
ours as they were using transgenic mice models of AD to
investigate whether Ab toxicity could be the cause of visual
disturbances in patients with AD. Our main focus here was to
investigate the accumulation of Ab in normal mice as a normal
ageing process. We observed an age-related accumulation of Ab
rich extracellular deposits along the Bruch’s membrane and also in
the outer segments of the photoreceptors in both human and
mouse with immunostaining. Western blot results in mouse tissue
showed that the most abundant types of Ab present in the retina
and in the RPE-choroidal tissues are the 22–36 kDa and the 50–
64 kDa oligomers. These Ab oligomers were also found in the
brain of an AD murine model [24]. In the brain of an AD
transgenic mice, it was demonstrated that 56 kDa Ab oligomers
are viable candidates for Ab assemblies that cause memory deficits
as they appear at 6 months old when memory deficit starts. The
27 kDa oligomers are present before memory impairment and
they do not affect memory function. Therefore the 50–64 kDa
bands obtained in this study may be the one that is toxic in the
retina. Lesne ´ et al. have also demonstrated that the level of the
56 kDa remains stable between 6 months and 13 months in the
brain and our result reflects the same pattern in our Western blot,
as there was no significant difference in the level of Ab in the
mouse retina and at the RPE/Bruch’s membrane between these
two age groups [24].
Ab is also deposited in the vascular network of the inner and
outer retina. Here the most marked feature was that while inner
retinal vessels accumulate Ab in a patchy progressive manner
along their length, choroidal vessels were different in that some
accumulate Ab deposits while others seem to remain Ab free.
There is a correlation between retinal degeneration and AD
[29,31] and it has been demonstrated that AD patients suffer
visual disturbances [40–42]. One reason for this may be because
such disturbances arise from the narrowing of retinal blood vessels
and decreased blood flow [43,44]. Ning et al. [29] have shown that
in a transgenic AD murine model, there is an accumulation of Ab
in the retinal and choroidal vasculature, which is consistent with
our finding of Ab deposition in vessels. This may explain the
narrowing of the retinal blood vessels and the decreased blood flow
found in AD patients.
Accumulation of Ab in the brain is intimately associated with
activated microglial cells and astrocytes. Microglia migrate in
response to the chemokine monocyte chemoattractant protein-1
(MCP-1), and cease migration upon interaction with immobilized
Ab [45]. Macrophages incorporate Ab in an internal attempt to
remove it [19,45]. In the retina, the presence of this incorporated
material makes macrophages detectable in vivo [46,47]. Retinal
macrophage numbers increase with age in mice [32,48], however,
they become less capable of digesting accumulated waste material
and appear overloaded with lipofuscin and Ab deposits [32]. As a
result, more macrophages are probably recruited in an attempt to
maintain a homeostasis between the accumulation of cellular
debris and its clearance.
In the brain, macrophage numbers have been increased
experimentally in a transgenic animal model of AD where amyloid
accumulation is marked. This resulted in not only a reduction in
amyloid accumulation, but also prevented cognitive decline [49].
It would be surprising if the same were not the case in the retina.
Many macrophages seen in older animals appeared bloated with
material that included Ab. As they were so bloated, their ability to
remove further quantities of Ab may have been compromised. As
in the brain, one way around this might be the recruitment of new
macrophages into the local environment. As we have shown,
macrophages in the retina do increase with age, but only over a
larger retinal area with no increase in local density. Once initially
established, macrophages appear to maintain exclusion territories
that restrict the entry of new cells into their matrix. New cells
appear to extend the coverage of the matrix but not its local
density.
Our study also reveals the presence of extracellular material at
the EM level specifically on photoreceptor outer segments. This is
a novel finding. The material appeared to initially accumulate at
Figure 7. There appeared to be a qualitative change in the morphology of deposits found on outer segments at 12 months of age.
The two panels show higher magnification scanning electron micrographs of debris on outer segments at 3 and 12 months. At the earlier stage the
deposits are largely spherical with thin processes connecting them to the wall of the outer segment. At 12 months very different picture is present.
Here the deposits appear as ruptured hemispheres that have partially collapsed leaving rough edges.
doi:10.1371/journal.pone.0013127.g007
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length with age, but at no point did this material encroach upon
the inner segment. This indicates that the focus of accumulation is
at the interface of the RPE with the photoreceptor outer segment
tip, implying that this accumulation of debris is in some way
related to a decline in the efficiency of the RPE phagocytotic
process [34,35]. If correct, then it would suggest that to fully
understand the ageing process in the outer retina, the age-related
changes in the RPE population and shifts in their efficiency must
be taken into account.
Significant differences were found in the intensity of the Ab
antibody staining on the outer segments around 12 months of age,
which coincides with a marked change in the appearance of
deposits at the EM level. Initially the deposits were roughly
spherical, but later many appeared to rupture giving the
appearance of distorted hemispheres with rough sharp edges.
The explanation for this distinct morphological change at this
stage remains illusive.
Given the large number of EM studies undertaken on the outer
retina over the years, it is rather surprising that deposition of
debris has not been reported before on outer segments. The
answer to this question probably relates to the electron density of
the material and the fact that most studies have used relatively
young animals with transmission EM. However, the images in this
study were generated by platinum coating a fractured surface of
the retina which will reveal 3 dimensional deposits on structures.
We assume that Ab is an element of these depositions as there is a
close association between the immunostaining pattern and the
scanning EM images. An additional consideration is that when Ab
is viewed with transmission EM it tends to be amorphous, and as
such is commonly missed unless specifically targeted [50,51].
Scanning EM has the advantage of providing a 3 dimensional
picture where extracellular deposition is much more obvious. Our
lab has undertaken transmission EM studies on aged rodent
photoreceptors where tissue is viewed in section, and failed to
identify the structures seen here [33], although re-examination of
the tissue now has revealed amorphous bodies with little structures
between the outer segments, particularly around their tips
(Unpublished observation).
With ageing many changes occur in the retina. Approximately
25–30% of rod photoreceptors are lost and those that remain
shorten by a similar proportion [33,52]. These changes are
probably associated with the distinct functional changes found in
the electroretinogram (ERG).Here,the amplitude ofcomponent
waves of the ERG, both receptoral and post receptoral, decline
in magnitude with age [53–56]. The outer retina has the largest
metabolic demand in the central nervous system [57,58], and
any deposition along Bruch’s membrane/RPE interface restrict-
ing its access to the choroidal blood supply is likely to be
detrimental to retinal function, probably contributing to age-
related cell loss. More intriguing, is the potential impact the
outer segment debris is likely to have upon photoreceptor
function, which is unknown.
Materials and Methods
Ethics Statement
All animals were used with University College London ethics
committee approval and under a UK Home Office project licence
(PPL 70/6571). All animal procedures conformed to the United
Kingdom Animal License Act 1986 (UK). Human eyes were
obtained from the eye bank at Moorfields Eye Hospital with the
approval of Moorfields and Whittington Research Ethics Com-
mittee (06/Q0504/78).
Animals and experimental paradigms
C57 BL/6 mice were housed in a temperature controlled
environment with a 12 hour day (160 lux) light/dark cycle. Three
groups of C57BL/6 mice were used, each containing 8 animals at
3, 6, 12 months (16 eyes per group). An additional 4 animals were
used at 24 months of age (8 eyes). Hence, 28 animals were used in
total. Both eyes were used from each animal. The 3, 6, and 12
months old animals were divided between 5 experiments. The first
was the non-invasive imaging of the outer retina/RPE undertaken
on the right eye prior to sacrifice. Four eyes from each group were
then used for cryosectioning and antibody staining. Four were
used for confocal SEM, four were taken for Western blot analysis
and four were used for whole mounts of the RPE surface. The
outer retina and Bruch’s membrane/RPE interface were the
targeted areas of interest because this is a key area for
accumulation of age-related deposits [37–39,59]. The 24 months
old animals were only used for retinal imaging followed by
antibody staining of whole mounts of the sub-retinal space and
SEM.
In vivo imaging
Mice were anaesthetized (6% Ketamine, (Fort Dodge, UK) 10%
Dormitor, (Pfizer, UK) and 84% sterile water at 5 ul/g
intraperitoneal injection) and their pupils were dilated (1%
tropicamide, Bausch and Lomb, UK). Fundus photographs were
taken with a digital camera mounted on a modified cSLO
(Heidelberg Retina Angiograph, Heidelberg Engineering, Ger-
many) where the pinhole diameter had been reduced to 100 mmt o
improve axial resolution, and the laser power increased to improve
signal-to-noise ratio. Power at the mouse pupil was measured to be
1400 mW at 488 nm.
Immunohistochemistry
All mice were sacrificed by exposure to CO2. The eyes were
removed and fixed in 4% paraformaldehyde in phosphate buffered
saline (PBS), pH 7.4 for 1 h. They were then cryo-preserved in
30% sucrose and embedded in optimal cutting temperature
compound (OCT, Agar Scientific UK). Cryostat sections were cut
at 10 mm and thaw-mounted onto charged slides. Immunohisto-
chemistry was performed at room temperature to reveal Ab on the
left sectioned eye and for Ab and microglia Iba-1 on the right eye
which was processed as a whole mount after cSLO imaging.
Sections were incubated for 1 h in 5% Normal Donkey serum
in 0.3% Triton X-100 in PBS, pH 7.4, followed by an overnight
incubation with the following primary antibodies; mouse mono-
clonal antibody to Ab 4G8 (1:500, Covance, UK) and rabbit
polyclonal antibody to Iba-1 (1:1000, A. Menarini Diagnostics,
UK). Primary antibodies were made in 1% Normal Donkey
Serum in 0.3% Triton X-100 in PBS. After Primary antibody
incubation, sections were washed three times in 0.1 M PBS and
then incubated in respective secondary antibodies conjugated with
either Alexa fluor 488 or 568 (Invitrogen Molecular Probes, UK),
made up in 2% Normal Donkey Serum in 0.3% Triton X-100 in
PBS at a dilution of 1:2000. These were added to the sections and
incubated for 1 h. In negative controls the primary antibody was
omitted. After secondary incubation sections were washed several
times and the nuclei stained with 49, 6-diamidino-2-phenylindole
(Sigma Aldrich, UK) for 1 min. Slides were then washed 3 times in
PBS and several times in Tris buffered Saline (pH 7.5). Slides were
mounted in Vectashield (VECTOR Laboratories, UK) and
coverslipped. Sections were viewed and images captured using
Epi-fluorescence and bright-field. 24-bit colour images were
captured at 384063072 pixel resolution.
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immunohistochemistry using the streptavidin horse radish perox-
idase complex. The sections of the eye were incubated for 1 hour
in a 5% Normal Donkey serum in 0.3% Triton X-100 in PBS,
pH 7.4, followed by an overnight incubation with the mouse
monoclonal antibody to amyloid beta which was made in 1%
Normal Donkey Serum in 0.3% Triton X-100 in PBS. After the
primary antibody incubation, the sections were washed three times
in 0.1 M PBS and then treated with 0.3% hydrogen peroxide in
PBS to quench endogenous peroxidase activity. After several
washes, the tissues were incubated with a biotin–SP conjugated
secondary antibody against mouse (Jackson ImmunoResearch
Laboratories, 1:1000) which were made up in 2% Normal Donkey
Serum in 0.3% Triton X-100 in PBS, were added to the sections
and incubated for 1 hour at room temperature. Negative controls
were done by omitting the primary antibody. After the secondary
antibody incubation, the sections were washed several times and
then incubated in a ready to use horseradish peroxidise
Streptavidin solution (VECTOR Laboratories, UK) for 30
minutes, followed by a peroxidase substrate solution, 3,3-
diaminobenzidine (DAB) for 1 minute. Slides were mounted in
Vectashield (VECTOR Laboratories, UK) and coverslipped after
several washes in PBS and TBS. Sections were viewed and images
captured using an Epi-fluorescence bright-field microscope
(Olympus BX50F4, Olympus, Japan), where data were captured
as 24-bit colour images at 384063072 pixel resolution using Nikon
DXM1200 (Nikon, Tokyo, Japan) digital camera.
For whole mounts, eyes were fixed as above and washed with
PBS directly after cSLO imaging. The cornea, lens and retina
were removed to expose the sub-retinal space. To flatten these
preparations, 5–6 radial cuts were made in each. After several
washes with PBS, the RPE-choroidal tissues were blocked and
permeabilised with 5% Normal Donkey serum with 3% (v/v)
Triton X-100 in PBS for 2 h.These were incubated overnight in
two primary antibodies: mouse monoclonal to Ab beta 4G8
(1:500, Covance, UK) and rabbit polyclonal antibody to Iba-1
(1:1000, A. Menarini Diagnostics, UK) in 1% Normal Donkey
Serum in 3% Triton X-100 in 0.1 M PBS. Preparations were
washed 3 times in PBS and incubated in respective secondary
antibodies made up in 2% Normal Donkey Serum in 0.3%
Triton X-100 in PBS at a dilution of 1:2000, and incubated for
2 h at room temperature. After secondary antibody incubation,
preparations were washed several times and the nuclei stained
as above. The RPE-choroidal tissues were then washed 3 times
in 0.1 M PBS and again in several washes in Tris buffered
Saline (pH 7.5) and mounted, coverslipped and imaged as
above.
Four human eyes were fixed in 10% formalin for at least
24 hours and then dissected whereby the lens, the sclera and the
RPE were removed and the retina were cut into smaller pieces.
After several washes in PBS, the retinae were cryoprotect in
sucrose and then embedded in OCT. 10 mm sections were made
and thaw-mounted onto charged slides. Immunohistochemistry
was performed at room temperature in the same way as it was
done with the mice eye sections.
The mouse monoclonal antibody to Ab 4G8 which was used in
immunohistochemistry and Western blot, is specific for the Ab
ectodomain (amino acid sequence 17–24 in human), a sequence
that does not overlap with that of secreted APP and is identical in
human, mouse and rat. Therefore this antibody excludes the
possibility that the protein expression observed in the immuno-
histochemistry and the bands obtained in the Western blot were
degradation products of soluble APP which lacks the Ab
ectodomain (Ab17–24) [24].
Scanning Electron Microscopy
Retinae were fixed in 2% paraformaldehyde and 2% glutalde-
hyde in PBS for 24 h, followed by washing in PBS and then post
fixed in 1% osmium tetroxide in 0.1 M PBS for 2 h. Tissues were
then thoroughly washed in distilled water and dehydrated through
a graded series of ethanol. The specimens were dried with a
critical dry point apparatus. After which they were coated with
platinum and analysed using a Carl Zeiss scanning electron
microscope.
Western blot analysis
The eyes were dissected on ice and the retina and RPE-
choroidal tissues separated and frozen in liquid nitrogen and
stored at 280uC The retina and RPE-choroidal tissues were
sequentially extracted. The samples were homogenized in 2%
sodium dodecyl sulfate with protease inhibitor cocktail (Roche
diagnostics), then centrifuged at 13,0006g. The supernatant was
then transferred to a new microcentrifuge tube and the resultant
pellet extracted with 70% formic acid in water. It was centrifuged
at 13,0006 g and the supernatant transferred to the microcen-
trifuge tube and the pellet discarded. The formic acid in the
supernatant was evaporated using a speed-Vac concentrator (The
Eppendorf Vacuum Concentrator, Brinkmann, USA) and the
protein pellet was reconstituted in 10% dimethyl sulfoxide in
2 mol/L Tris-HCl. The protein concentration was measured with
an absorbance of 450 nm. Equal amounts of proteins were
separated by a 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and electrophoretically transferred onto nylon
membranes. The membranes containing the transferred proteins
were pre-treated with 5% non-fat dried milk in 1 M PBS (pH 7.4)
overnight and incubated for 1 h with monoclonal Ab antibody
(1:1000, Covance) followed by several washes in 0.05% Tween-20
in 1 M PBS. The membranes were then incubated with a goat
anti-mouse IgG peroxidise conjugated secondary antibody (1:10
000, Thermo Scientific) for 1 h. Ab immunoreactivity was
visualized by exposing x-ray film to blots incubated with ECL
reagent (SuperSignal West Pico, Thermo Scientific, UK). Total
protein profile was determined by gel staining with Coomassie
Blue to check that protein extraction was consistent.
Analysis
Measurement of the distance between macrophages.
Images of clustered and individual macrophages for 12 and 24
months were captured using a 40X objective lens and a 10X eyepieces
in JPEG format using Epi-fluorescence bright-field with a 24-bit
colour images at 384063072 pixel resolution using Nikon DXM1200
(Nikon, Tokyo, Japan) digital camera. Images were put together using
Adobe Photoshop CS4 and the dendrite’s length was measured from
the centre of the nucleus of the macrophage to the end of dendrites.
To determine whether macrophages were regularly spaced, small
clusters of six cells were photographed as above and the distances
between the nucleus of each cell and its nearest neighbour were
measured.
Counting of macrophages. Images were captured using a
20X objective lens and a 10X eyepieces in JPEG format using the
Epi-fluorescence bright-field microscope with a 24-bit colour
images at 384063072 pixel resolution using a Nikon DXM1200
digital camera. The images were then put together by Adobe
Photoshop CS4 extended. The iba-1 positive cells were counted
using the count tool.
Measurement of Ab in Bruch’s membrane/RPE interface
and photoreceptor in immunostaining. Fluorescence images
of the area around the optic nerve head were taken in JPEG
format using a 40X objective lens and a 10X eyepieces, using an
Amyloid b in Ageing Mouse Eye
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Olympus, Japan) with a 24-bit colour images at 384063072
pixel resolution using Nikon DXM1200 (Nikon, Tokyo, Japan)
digital camera. The pictures were put together and the integrated
density which is the product of the area chosen (in pixels) and the
mean gray value (the measurement of the brightness) were
measured using Adobe Photoshop CS4 extended. The lasso tool
was used to draw a line all the way around the Bruch’s membrane
and the integrated density was measured. The same goes for the
outer segments whereby the line was drawn around the outer
segments of the photoreceptor.
Measurement of Ab in RPE-choroidal and retina in
Western blot. The scanned pictures of the protein gel were
inverted to grayscale format and the mean gray value was
measured for each protein band by using the lasso tool to draw a
line all the way around the edges of the band using Adobe
Photoshop CS4 extended. The absolute intensity was calculated by
multiplying the mean gray value and the pixel value.
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